Afghanistan vs Saudi Arabia: HIV-positive TB patients on ART (antiretroviral therapy)
Afghanistan
100.0%
in 2024
Saudi Arabia
100.0%
in 2024
Afghanistan rank
1st
Saudi Arabia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Afghanistan
- Saudi Arabia
How they compare
Afghanistan currently reports 100.0% against 100.0% in Saudi Arabia, a difference of 0.0%.
The two have swapped places 1 time across 9 shared years of data; in 2016 it was Afghanistan ahead.
Afghanistan ranks 1st and Saudi Arabia ranks 1st of 144 countries.
Saudi Arabia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 62.5% | 99.0% | 36.5% | Saudi Arabia |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Afghanistan or Saudi Arabia?
- Afghanistan, at 100.0% against 100.0% in Saudi Arabia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Afghanistan and Saudi Arabia?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Saudi Arabia?
- 9 years are reported by both, from 2016 to 2024.
- How do Afghanistan and Saudi Arabia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Afghanistan ranks 1st and Saudi Arabia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.